DAWES KAREN A
SEC CIK 1261506 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RGEN | REPLIGEN CORP | Dir | 92.8K | — | $11.55M | 25 | 2021-07-13 | 2026-05-14 |
Most active insiders at RGEN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hunt Anthony | Dir | — | $7.01M |
| 2 | Loeillot Olivier | CEO, Dir | — | $4.19M |
| 3 | Bylund James | COO | — | $331.3K |
| 4 | Garland Jason K | CFO | — | $185.8K |
| 5 | DAWES KAREN A | Dir | — | $44.3K |
| 6 | Douglass Brian Robb | Chief PRODUCT Off | — | — |
| 7 | Pax Margaret | Dir | — | — |
| 8 | Hughes Violetta | CAO | — | — |
| 9 | Mhatre Rohin | Dir | — | — |
| 10 | Konstantinov Konstantin | Dir | — | — |
Transactions 25
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-18 16:05 | 2026-05-14 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | A - Grant | $0.00 | +995 | 92.8K | +1% | $0 |
| 2025-12-18 | 2025-12-17 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | S - Sale | $161.00 | -275 | 91.8K | -0.3% | -$44.3K | |
| D | 2025-05-19 | 2025-05-15 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | A - Grant | $0.00 | +973 | 92.1K | +1% | $0 |
| D | 2024-06-14 | 2024-06-14 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | M - OptEx | $67.71 | +2,953 | 88.2K | +3% | +$199.9K |
| D | 2024-05-20 | 2024-05-16 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | A - Grant | $0.00 | +803 | 88.2K | +0.9% | $0 |
| D | 2024-02-28 | 2024-02-27 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | S - Sale+OE | $193.35 | -1,000 | 87.4K | -1% | -$193.3K |
| D | 2024-02-28 | 2024-02-27 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | M - OptEx | $42.07 | +4,626 | 88.4K | +6% | +$194.6K |
| D | 2023-08-30 | 2023-08-29 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | S - Sale+OE | $171.38 | -850 | 83.7K | -1% | -$145.7K |
| D | 2023-08-30 | 2023-08-29 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | M - OptEx | $18.12 | +7,392 | 84.6K | +10% | +$133.9K |
| D | 2023-05-22 | 2023-05-18 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | A - Grant | $0.00 | +798 | 77.2K | +1% | $0 |
| 2022-09-09 | 2022-09-09 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | S - Sale | $227.17 | -775 | 76.4K | -1% | -$176.1K | |
| D | 2022-05-31 | 2022-05-26 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | A - Grant | $0.00 | +644 | 77.2K | +0.8% | $0 |
| M | 2022-05-26 | 2022-05-25 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | S - Sale | $150.51 | -14.7K | 81.0K | -15% | -$2.21M |
| DM | 2021-11-12 | 2021-11-10 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | S - Sale+OE | $263.93 | -4,783 | 91.3K | -5% | -$1.26M |
| D | 2021-11-12 | 2021-11-10 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | M - OptEx | $26.12 | -4,783 | 96.0K | -5% | -$124.9K |
| M | 2021-11-04 | 2021-11-02 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | S - Sale | $303.94 | -2,400 | 92.9K | -3% | -$729.5K |
| M | 2021-09-15 | 2021-09-14 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | S - Sale | $294.26 | -274 | 93.8K | -0.3% | -$80.6K |
| D | 2021-09-02 | 2021-09-01 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | M - OptEx | $38.76 | -3,459 | 97.4K | -3% | -$134.1K |
| DM | 2021-09-02 | 2021-09-01 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | S - Sale+OE | $283.91 | -3,459 | 94.8K | -4% | -$982.1K |
| M | 2021-08-19 | 2021-08-17+ | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | S - Sale | $254.18 | -18.9K | 95.4K | -17% | -$4.80M |
| DMA | 2021-07-22 | 2021-07-13 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | S - Sale+OE | $202.23 | -1,520 | 117.5K | -1% | -$307.4K |
| DA | 2021-07-22 | 2021-07-13 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | M - OptEx | $41.19 | +2,929 | 119.0K | +3% | +$120.6K |
| M | 2021-07-22 | 2021-07-20 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | S - Sale | $202.09 | -4,585 | 112.9K | -4% | -$926.6K |
| D | 2021-07-15 | 2021-07-13 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | S - Sale+OE | $202.23 | +1,520 | 117.5K | +1% | +$307.4K |
| D | 2021-07-15 | 2021-07-13 | RGEN | REPLIGEN CORP | DAWES KAREN A | Dir | M - OptEx | $41.19 | +2,929 | 119.0K | +3% | +$120.6K |
Purchase Sale Sale after option exercise All abbreviations